NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice

Dunn, 2004, The immunobiology of cancer immunosurveillance and immunoediting, Immunity, 21, 137, 10.1016/j.immuni.2004.07.017 Swann, 2007, Immune surveillance of tumors, J. Clin. Invest., 117, 1137, 10.1172/JCI31405 Diefenbach, 2002, The innate immune response to tumors and its role in the induction of T-cell immunity, Immunol. Rev., 188, 9, 10.1034/j.1600-065X.2002.18802.x Iannello, 2016, Immunosurveillance and immunotherapy of tumors by innate immune cells, Curr. Opin. Immunol., 38, 52, 10.1016/j.coi.2015.11.001 Beatty, 2015, Immune escape mechanisms as a guide for cancer immunotherapy, Clin. Cancer Res., 21, 687, 10.1158/1078-0432.CCR-14-1860 Schreiber, 2011, Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion, Science, 331, 1565, 10.1126/science.1203486 Marcus, 2014, Recognition of tumors by the innate immune system and natural killer cells, Adv. Immunol., 122, 91, 10.1016/B978-0-12-800267-4.00003-1 Waldhauer, 2008, NK cells and cancer immunosurveillance, Oncogene, 27, 5932, 10.1038/onc.2008.267 Kennedy, 2000, Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice, J. Exp. Med., 191, 771, 10.1084/jem.191.5.771 Lodolce, 1998, IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation, Immunity, 9, 669, 10.1016/S1074-7613(00)80664-0 Orange, 2013, Natural killer cell deficiency, J. Allergy Clin. Immunol., 132, 515, 10.1016/j.jaci.2013.07.020 Wang, 2015, NK Cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy, Front. Immunol., 6, 368, 10.3389/fimmu.2015.00368 Bachanova, 2014, NK cells in therapy of cancer, Crit. Rev. Oncog., 19, 133, 10.1615/CritRevOncog.2014011091 Restifo, 2012, Adoptive immunotherapy for cancer: harnessing the T cell response, Nat. Rev. Immunol., 12, 269, 10.1038/nri3191 Dubois, 2008, Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action, J. Immunol., 180, 2099, 10.4049/jimmunol.180.4.2099 Brabb, 1997, Separately expressed T cell receptor alpha and beta chain transgenes exert opposite effects on T cell differentiation and neoplastic transformation, Eur. J. Immunol., 27, 3039, 10.1002/eji.1830271142 Jacobs, 1996, Oncogenic potential of a pre-T cell receptor lacking the TCR beta variable domain, Oncogene, 12, 2089 Kelly, 2003, Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma, J. Exp. Med., 198, 79, 10.1084/jem.20021548 Newrzela, 2012, T-cell receptor diversity prevents T-cell lymphoma development, Leukemia, 26, 2499, 10.1038/leu.2012.142 Serwold, 2010, T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell, Proc. Natl. Acad. Sci. U.SA., 107, 18939, 10.1073/pnas.1013230107 Wang, 1997, CD3-epsilon overexpressed in prothymocytes acts as an oncogene, Mol. Med., 3, 72, 10.1007/BF03401669 Pancewicz, 2010, Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia, Proc. Natl. Acad. Sci. U.S.A., 107, 16619, 10.1073/pnas.1010722107 O'Neil, 2006, Activating Notch1 mutations in mouse models of T-ALL, Blood, 107, 781, 10.1182/blood-2005-06-2553 Weng, 2004, Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science, 306, 269, 10.1126/science.1102160 Nakagawa, 2014, Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma, J. Exp. Med., 211, 2497, 10.1084/jem.20140987 Stein, 2000, CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features, Blood, 96, 3681, 10.1182/blood.V96.12.3681 Jensen, 2004, Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity, Immunol.1 Res., 29, 81, 10.1385/IR:29:1-3:081 Shankaran, 2001, IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, 410, 1107, 10.1038/35074122 Street, 2004, Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells, J. Exp. Med., 199, 879, 10.1084/jem.20031981 Kohnken, 2017, Overview of the use of murine models in leukemia and lymphoma research, Front. Oncol., 7, 22, 10.3389/fonc.2017.00022 Costello, 2002, Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia, Blood, 99, 3661, 10.1182/blood.V99.10.3661 Pierson, 1996, CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis, Blood, 88, 2279, 10.1182/blood.V88.6.2279.bloodjournal8862279 Phan, 2016, T-cell lymphoma epidemiology: the known and unknown, Curr. Hematol. Malig. Rep., 11, 492, 10.1007/s11899-016-0353-y Ritter, 2018, T-cell repertoires in refractory coeliac disease, Gut, 67, 644 Utz, 1996, Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion, J. Virol., 70, 843, 10.1128/jvi.70.2.843-851.1996 Egorov, 2018, The changing landscape of naive T cell receptor repertoire with human aging, Front. Immunol., 9, 1618, 10.3389/fimmu.2018.01618